📑Generic Anti-Infective Drugs
Procurement process summary
This process is to purchase Generic Anti-Infective Drugs.
This contract was awarded by 🇬🇧 eTenderwales for an amount of GBP 52,634 to 1 supplier. It was published on 2017-06-21 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇧 eTenderwales Buying unitnot reported Publication date2017-06-21 Contest statusnot reported DescriptionGeneric Anti-Infective Drugs.Awards
This award was granted to Crescent Pharma Limited by eTenderwales for an amount of GBP 52,634. The procurement process was conducted through open for the category of goods. The award was granted on 2018-02-21. This is award number 7.
This contract has multiple awards. This is award number 7. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇬🇧 Crescent Pharma Limited | GBP 52,634 | 2018-02-21 | 7 |
Market context and opportunities
The execution of this contract allows the entity eTenderwales to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUK_ocds-70d2nz-0ebcfeec-0a86-4860-8d70-e47ca925c473-award-7Publication date2017-06-21Contract datenot reportedAward date2018-02-21CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
